China Bars GlaxoSmithKline Exec From Fleeing Country, GSK Allegedly Spent $489 Million on Bribes
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
Beijing is preventing GlaxoSmithKline's (GSK.L) head of finance for China from leaving the country, as police accuse the British drugmaker of bribing officials and doctors, a spokesman for the drugmaker said on Wednesday. The travel restrictions on Steve Nechelput were imposed at the end of June and he continues to carry out his work in China, as well as being free to move around the country. He has not been questioned, arrested or detained by police, the spokesman added.
Help employers find you! Check out all the jobs and post your resume.
Beijing is preventing GlaxoSmithKline's (GSK.L) head of finance for China from leaving the country, as police accuse the British drugmaker of bribing officials and doctors, a spokesman for the drugmaker said on Wednesday. The travel restrictions on Steve Nechelput were imposed at the end of June and he continues to carry out his work in China, as well as being free to move around the country. He has not been questioned, arrested or detained by police, the spokesman added.
Help employers find you! Check out all the jobs and post your resume.